Cancer

Cancer is a condition where cells in a specific part of the body grow and reproduce uncontrollably. Cancer Center Amsterdam experts aim to create groundbreaking new possibilities for patients with cancer. Read about our latest insights and activities on cancer.

October 1, 2024
ADORE: €9 Million Grant from Dutch Research Council (NWO) and ‘The Largest Bingo Ever’ ADORE (Amsterdam Oncology and Neuroscience Research) represents a groundbreaking approach to collaborative research at Amsterdam UMC. By uniting cancer researchers and neuroscientists, the initiative aims to develop new diagnostics and more targeted therapies. Despite differences between cancer and neurodegenerative diseases, ADORE focuses on their shared mechanisms to accelerate medical breakthroughs.
- Cancer
- Brain & Psychiatry
March 4, 2024
Improving access to early-stage lung cancer care in Europe There are stark differences between European countries when it comes to both the reimbursement of, and access to, new treatments for patients with early-stage lung cancer. There are also differences in reimbursement times and indications between the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA). Researchers from Amsterdam UMC Cancer Center Amsterdam analysed the landscape, and their results are published today in The Lancet Regional Health Europe as part of a series on the latest developments in the treatment of this lung cancer.
- Cancer
December 18, 2023
Reinventing the wheel with 'organoids' Organoids are complex, three-dimensional cell cultures, which are gaining an increasingly important place in medical research. To prevent all research groups from reinventing the same wheel, Amsterdam UMC has now set up a special centre to bundle the work on organoids: the ORCAU.
- Cancer
November 29, 2023
Measuring tumours quickly and precisely thanks to AI The CAESAR research group at Amsterdam UMC have developed an AI tool that automatically shows liver tumours on CT scans of patients with colon cancer that has spread to the liver, giving doctors quick insight into the size of the tumours. The fact that the tool is now being researched in the doctor's daily practice is good news, as many AI tools are stuck in the development phase. Researcher Michiel Zeeuw explains how this software came about.
- Cancer
- Artificial Intelligence
November 23, 2023
AI system helps recognize early stage of oesophageal cancer A new AI system can help endoscopists recognize oesophageal cancer early, according to a study by Amsterdam UMC and Eindhoven University of Technology. "The sooner you recognize oesophageal cancer, the better the outcome for the patient," says Jacques Bergman, professor of Endoscopy at Amsterdam UMC. "We are therefore very happy with this help from artificial intelligence."
- Cancer
- Artificial Intelligence
September 25, 2023
Lasker Award for Piet Borst Piet Borst, emeritus professor of clinical biochemistry and molecular biology at the Faculty of Medicine of the University of Amsterdam, has received 2023 Lasker-Koshland Special Achievement Award in Medical Science. He receives this 'American Nobel Prize' thanks to his numerous scientific discoveries in the field of cancer.
- Cancer
July 7, 2023
Keyhole surgery safe and less invasive for patients with pancreatic cancer Thanks to a large international study, keyhole surgery has been shown to be a safe and less invasive option for pancreatic cancer patients undergoing surgery. These results are published today in The Lancet Regional Health Europe. Professor Mohammad Abu Hilal, from the University of Southampton and a surgeon in Brescia, Italy: “the biggest news is that we now have strong scientific evidence that keyhole surgery is safe for left-sided pancreatic cancer.”
- Cancer
May 26, 2023
Targeted combination therapy more effective than chemotherapy in patients with chronic lymphatic leukemia Chemotherapy has until now been the most effective treatment for young and fit patients with chronic lymphatic leukemia (CLL). According to research led by researchers from the University of Cologne, Amsterdam UMC and the University of Copenhagen targeted combination therapy without chemo is more effective and also produces fewer side effects.
- Cancer
May 11, 2023
Combination therapy outperforms chemotherapy in patients with chronic lymphocytic leukaemia Chemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukaemia (CLL). The disease is the most common form of leukaemia in the Western world, causing a substantial health burden on patients and society. It is currently incurable. Research led by researchers from Cologne University, Amsterdam UMC and Copenhagen University, now shows that a chemofree drug-combination therapy is more effective and produces fewer side effects. The results of this study are published today in the New England Journal of Medicine.

Cancer

We use cookies